{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:21:25Z","timestamp":1778538085962,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ajp.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T12:18:55Z","timestamp":1551788335000},"page":"13-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Clozapine-induced agranulocytosis and leukopenia: Incidence, associated factors, and rate of hematologic adverse-effects monitoring in psychiatric out-patient services in Thailand"],"prefix":"10.1016","volume":"41","author":[{"given":"Noppawan","family":"Tunsirimas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornjira","family":"Pariwatcharakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somrak","family":"Choovanichvong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woraphat","family":"Ratta-apha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajp.2019.03.002_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/YIC.0000000000000060","article-title":"Clozapine-associated neutropenia and agranulocytosis in Argentina (2007\u20132012)","volume":"30","author":"Balda","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2019.03.002_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajp.2016.01.012","article-title":"FDA changes clozapine monitoring guidelines: implications for worldwide practice","volume":"21","author":"Bastiampillai","year":"2016","journal-title":"Asain J. Psychiatr."},{"issue":"3","key":"10.1016\/j.ajp.2019.03.002_bib0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3371\/1935-1232.10.3.163","article-title":"Guide to the management of clozapine-related tolerability and safety concerns","volume":"10","author":"Citrome","year":"2016","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"10","key":"10.1016\/j.ajp.2019.03.002_bib0020","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4088\/JCP.11r06977","article-title":"Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy","volume":"73","author":"Cohen","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2019.03.002_bib0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1039856213491990","article-title":"Clozapine and agranulocytosis: re-assessing the risks","volume":"21","author":"Drew","year":"2013","journal-title":"Australas Psychiatry"},{"key":"10.1016\/j.ajp.2019.03.002_bib0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajp.2018.12.011","article-title":"A qualitative exploration of clozapine prescribing and monitoring practices in the Arabian Gulf countries","volume":"39","author":"Ismail","year":"2019","journal-title":"Asian J. Psychiatr."},{"issue":"6","key":"10.1016\/j.ajp.2019.03.002_bib0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/hup.779","article-title":"Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?","volume":"21","author":"Kang","year":"2006","journal-title":"Hum. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.ajp.2019.03.002_bib0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.9758\/cpn.2016.14.4.323","article-title":"Clozapine monitoring in clinical practice: beyond the mandatory requirement","volume":"14","author":"Kar","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"5","key":"10.1016\/j.ajp.2019.03.002_bib0045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/JCP.0000000000000387","article-title":"The effect of clozapine on hematological indices: a 1-year follow-up study","volume":"35","author":"Lee","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.ajp.2019.03.002_bib0050","first-page":"2175","article-title":"The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital","volume":"90","author":"Maskasame","year":"2007","journal-title":"J. Med. Assoc. Thai."},{"issue":"2","key":"10.1016\/j.ajp.2019.03.002_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13651500903402450","article-title":"Incidence and risk for neutropenia\/agranulocytosis among clozapine users: a retrospective cohort study","volume":"14","author":"Ratanajamit","year":"2010","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"3","key":"10.1016\/j.ajp.2019.03.002_bib0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/pds.4156","article-title":"Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case-control study","volume":"26","author":"Sing","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"8","key":"10.1016\/j.ajp.2019.03.002_bib0065","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16m11152","article-title":"Evaluating the effect of the changes in FDA guidelines for clozapine monitoring","volume":"78","author":"Sultan","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2019.03.002_bib0070","first-page":"229","article-title":"Incidence of leukopenia and agranulocytosis in 239 Thai patients treated with clozapine","volume":"45","author":"Udomratn","year":"2000","journal-title":"J. Psychiatr. Assoc. Thailand"},{"issue":"4","key":"10.1016\/j.ajp.2019.03.002_bib0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4103\/0253-7176.140738","article-title":"Late onset clozapine induced agranulocytosis","volume":"36","author":"Velayudhan","year":"2014","journal-title":"Indian J. Psychol. Med."},{"issue":"6","key":"10.1016\/j.ajp.2019.03.002_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066154","article-title":"Use of clozapine in older Asian patients with schizophrenia between 2001 and 2009","volume":"8","author":"Xiang","year":"2013","journal-title":"PLoS One"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201818308141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201818308141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:31:22Z","timestamp":1761755482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201818308141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":16,"alternative-id":["S1876201818308141"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2019.03.002","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine-induced agranulocytosis and leukopenia: Incidence, associated factors, and rate of hematologic adverse-effects monitoring in psychiatric out-patient services in Thailand","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}